Coe, F, Misra, V, McCabe, Y, Adderley, H, Woodhouse, L, Ayub, Z, Wang, X, Howell, S & Ekholm, M 2022, ' Average duration of prior treatment lines predicts clinical benefit to eribulin chemotherapy in patients with metastatic breast cancer ', Breast Cancer Research and Treatment, vol. 191, no. 3, pp. 535-543 . https://doi.org/10.1007/s10549-021-06438-7
Howell, S J, Coe, F, Wang, X, Horsley, L & Ekholm, M 2020, ' Carboplatin dose capping affects pCR rate in HER2-positive breast cancer patients treated with neoadjuvant Docetaxel, Carboplatin, Trastuzumab, Pertuzumab (TCHP) ', Breast Cancer Research and Treatment, vol. 184, no. 2, pp. 481-489 . https://doi.org/10.1007/s10549-020-05868-z Breast Cancer Research and Treatment